Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
AI-EBUS-Elastography for LN Staging
- Status
- COMPLETED
- Phase
- NA
Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations
- Status
- UNKNOWN
- Phase
- PHASE2
A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC
- Status
- RECRUITING
- Phase
- N/A
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)
- Status
- UNKNOWN
- Phase
- NA
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
- Status
- RECRUITING
- Phase
- PHASE1
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy
- Status
- UNKNOWN
- Phase
- N/A
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
- Status
- RECRUITING
- Phase
- NA
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers
- Status
- RECRUITING
- Phase
- N/A
A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1